Anti-β2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome
Authors:
- 1 June 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 120 (3) , 537-543
Abstract
We examined the role of autoantibodies to β2-GPI and prothrombin (PT) in the inhibition of annexin V binding to cardiolipin (CL) and the association with clinical manifestations of the anti-phospholipid syndrome (APS). Plasma samples from 59 patients with anti-phospholipid (aPL) antibodies were studied. Affinity purification of total IgG and IgG anti-ß2-GPI antibodies was performed using staphylococcal protein A and phospholipid liposomes. Annexin V binding to CL was significantly inhibited by 31/59 (53%) aPL+ plasma samples. There was a significant association between annexin V inhibition and elevated levels of IgG anti-cardiolipin (aCL) (r = −0·62; P < 0·001), IgG anti-ß2-GPI (r = −0·67; P < 0·001) and a weaker association with lupus anti-coagulant (r = −0·27; P = 0·05). There was no association with other isotypes of aCL and anti-ß2-GPI or with anti-PT of any isotype. In patients with clinical manifestations of the APS there were higher levels of IgG aCL (median (range) Z score): 10·0 (0–17·6) versus 5·0 (0–16·1); P = 0·03), IgG anti-ß2-GPI (4·5 (0–11·3) versus 0·9 (0–9·7); P = 0·02) and greater inhibition of annexin V binding to CL (−3·4 (−11·4–0·6) versus−1·1 (−10·8–1·2); P = 0·22). Odds ratios for the laboratory assays and the presence of clinical manifestations of the APS varied between 0·38 and 4·16, with the highest values for IgG aCL (4·16), IgG anti-ß2-GPI (3·28) and annexin V inhibition (2·85). Additional experiments with affinity-purified IgG antibodies indicated that inhibition of annexin V binding was dependent upon the concentration of ß2-GPI and anti-ß2-GPI antibodies. These results indicate that inhibition of annexin V binding to procoagulant phospholipid surfaces is dependent upon anti-ß2-GPI antibodies and suggest a role for annexin V in the pathogenesis of the APS.Keywords
This publication has 40 references indexed in Scilit:
- International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshopArthritis & Rheumatism, 1999
- Antiphospholipid antibodies and the antiphospholipid antibody syndromeJournal of the American Academy of Dermatology, 1997
- Immunology of the antiphospholipid antibody syndromeArthritis & Rheumatism, 1996
- Studies on the interaction of placental anticoagulant protein I, β2glycoprotein 1, and antiphospholipid antibodies in the prothrombinase reaction and in the solid phase anticardiolipin assaysJournal of Laboratory and Clinical Medicine, 1996
- A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with InfectionLupus, 1992
- β2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipinThe Lancet, 1990
- Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactorThe Lancet, 1990
- The “Primary” Antiphospholipid SyndromeMedicine, 1989
- Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive PatientsMedicine, 1989
- Anticardiolipin response in acute infectionsClinical Immunology and Immunopathology, 1986